Clinical Trial Update: Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial comparing clindamycin phosphate 1% gel to once-daily dapsone 5% gel for moderate acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clindamycin phosphate 1% gel (clindamycin phosphate)
• Dapsone 5% gel (dapsone)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED